The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: Implications in targeted cancer therapies

[1]  T. He,et al.  BMP9 signaling in stem cell differentiation and osteogenesis. , 2018, American journal of stem cells.

[2]  K. Cadigan.  Faculty of 1000 evaluation for Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. , 2017 .

[3]  Hailin Tang,et al.  LGR5 Promotes Breast Cancer Progression and Maintains Stem‐Like Cells Through Activation of Wnt/β‐Catenin Signaling , 2015, Stem cells.

[4]  T. He,et al.  The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways. , 2015, Current cancer drug targets.

[5]  Yezi Zhu,et al.  Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3‐AR axis inhibition , 2015, The Prostate.

[6]  K. Guan,et al.  YAP and TAZ: a nexus for Hippo signaling and beyond. , 2015, Trends in cell biology.

[7]  Young Chul Kim,et al.  Alternative Wnt Signaling Activates YAP/TAZ , 2015, Cell.

[8]  A. Maitra,et al.  β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis , 2015, Genes & development.

[9]  J. Iovanna,et al.  Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence , 2015, Oncoscience.

[10]  K. Hansen,et al.  β-Catenin Regulates Primitive Streak Induction through Collaborative Interactions with SMAD2/SMAD3 and OCT4. , 2015, Cell stem cell.

[11]  H. Clevers,et al.  Repairing organs: lessons from intestine and liver. , 2015, Trends in genetics : TIG.

[12]  D. Virshup,et al.  Targeting Wnts at the Source—New Mechanisms, New Biomarkers, New Drugs , 2015, Molecular Cancer Therapeutics.

[13]  O. Klein,et al.  Opposing activities of Notch and Wnt signaling regulate intestinal stem cells and gut homeostasis. , 2015, Cell reports.

[14]  Moonsup Lee,et al.  FOXKs promote Wnt/β-catenin signaling by translocating DVL into the nucleus. , 2015, Developmental cell.

[15]  M. Salto‐Tellez,et al.  Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression , 2015, Modern Pathology.

[16]  K. Xie,et al.  Pancreatic cancer stromal biology and therapy , 2015, Genes & diseases.

[17]  B. Göttgens,et al.  The Endothelial Transcription Factor ERG Promotes Vascular Stability and Growth through Wnt/β-Catenin Signaling , 2015, Developmental cell.

[18]  Jian Cao,et al.  Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas , 2015, Genes & diseases.

[19]  F. Baas,et al.  Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma , 2014, PloS one.

[20]  R. Nusse,et al.  An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.

[21]  S. Dupont,et al.  The biology of YAP/TAZ: hippo signaling and beyond. , 2014, Physiological reviews.

[22]  C. Chai,et al.  Wntless (GPR177) expression correlates with poor prognosis in B-cell precursor acute lymphoblastic leukemia via Wnt signaling. , 2014, Carcinogenesis.

[23]  D. Medici,et al.  Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.

[24]  T. He,et al.  Wnt versus Hippo: A balanced act or dynamic duo? , 2014, Genes & diseases.

[25]  M. Kahn,et al.  Safely targeting cancer stem cells via selective catenin coactivator antagonism , 2014, Cancer science.

[26]  L. Burrus,et al.  Concentration‐dependent effects of WNTLESS on WNT1/3A signaling , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.

[27]  Manisha Sharma,et al.  Targeting the β-catenin nuclear transport pathway in cancer. , 2014, Seminars in cancer biology.

[28]  R. Haydon,et al.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases , 2014, Genes & diseases.

[29]  Giuseppe Basso,et al.  YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response , 2014, Cell.

[30]  C. Landen,et al.  Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. , 2014, Gynecologic oncology.

[31]  Michael Kahn,et al.  Can we safely target the WNT pathway? , 2014, Nature Reviews Drug Discovery.

[32]  P. Sun,et al.  Pygo2 regulates β-catenin–induced activation of hair follicle stem/progenitor cells and skin hyperplasia , 2014, Proceedings of the National Academy of Sciences.

[33]  Maojuan Guo,et al.  A Cocktail Method for Promoting Cardiomyocyte Differentiation from Bone Marrow-Derived Mesenchymal Stem Cells , 2014, Stem cells international.

[34]  K. Brennan,et al.  Wnt–Notch signalling crosstalk in development and disease , 2014, Cellular and Molecular Life Sciences.

[35]  T. He,et al.  Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. , 2014, Stem cells and development.

[36]  Yonghe Li,et al.  Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells. , 2014, Cellular signalling.

[37]  J. Rossant,et al.  Stroma provides an intestinal stem cell niche in the absence of epithelial Wnts , 2014, Development.

[38]  F. Bard,et al.  WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. , 2014, Developmental cell.

[39]  Gi Fay Mok,et al.  Smad1 transcription factor integrates BMP2 and Wnt3a signals in migrating cardiac progenitor cells , 2014, Proceedings of the National Academy of Sciences.

[40]  W. B. van den Berg,et al.  Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8. , 2014, Cellular signalling.

[41]  Yezi Zhu,et al.  Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer , 2014, Clinical Cancer Research.

[42]  Xaralabos Varelas,et al.  The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease , 2014, Development.

[43]  K. Kobielak,et al.  Wnt7b Is an Important Intrinsic Regulator of Hair Follicle Stem Cell Homeostasis and Hair Follicle Cycling , 2014, Stem cells.

[44]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[45]  Yonghe Li,et al.  Effect of Niclosamide on Basal-like Breast Cancers , 2014, Molecular Cancer Therapeutics.

[46]  V. Kríz,et al.  Monensin Inhibits Canonical Wnt Signaling in Human Colorectal Cancer Cells and Suppresses Tumor Growth in Multiple Intestinal Neoplasia Mice , 2014, Molecular Cancer Therapeutics.

[47]  S. Bellusci,et al.  Regulation of Induced Pluripotent Stem (iPS) Cell Induction by Wnt/β-Catenin Signaling* , 2014, The Journal of Biological Chemistry.

[48]  D. Zheng,et al.  In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators , 2014, Nature Cell Biology.

[49]  W. Sellers,et al.  Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974 , 2013, Proceedings of the National Academy of Sciences.

[50]  Giusi Moffa,et al.  Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells , 2013, Nature Communications.

[51]  C. Nguyên,et al.  The Small Molecule Wnt Signaling Modulator ICG-001 Improves Contractile Function in Chronically Infarcted Rat Myocardium , 2013, PloS one.

[52]  W. Hsu,et al.  Gpr177 regulates pulmonary vasculature development , 2013, Development.

[53]  A. Gurney,et al.  Canonical wnt signaling is required for pancreatic carcinogenesis. , 2013, Cancer research.

[54]  S. Krauss,et al.  Tankyrases as drug targets , 2013, The FEBS journal.

[55]  H. Clevers.  The Intestinal Crypt, A Prototype Stem Cell Compartment , 2013, Cell.

[56]  M. Kahn,et al.  Wnt/β‐catenin signalling induces MLL to create epigenetic changes in salivary gland tumours , 2013, The EMBO journal.

[57]  Hideki Yamamoto,et al.  The apical and basolateral secretion of Wnt11 and Wnt3a in polarized epithelial cells is regulated by different mechanisms , 2013, Journal of Cell Science.

[58]  C. Nguyên,et al.  Small molecule inhibition of CBP/catenin interactions eliminates drug resistant clones in acute lymphoblastic leukemia , 2013, Oncogene.

[59]  S. Krauss,et al.  A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. , 2013, Cancer research.

[60]  W. Birchmeier,et al.  Wnt signaling in stem and cancer stem cells. , 2013, Current opinion in cell biology.

[61]  W. Hsu,et al.  Gpr177 Deficiency Impairs Mammary Development and Prohibits Wnt-Induced Tumorigenesis , 2013, PloS one.

[62]  J. M. García-Martínez,et al.  Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer. , 2013, Molecular cell.

[63]  T. He,et al.  Wnt signaling in bone formation and its therapeutic potential for bone diseases , 2013, Therapeutic advances in musculoskeletal disease.

[64]  R. Nusse,et al.  Wnt signaling in skin development, homeostasis, and disease. , 2013, Cold Spring Harbor perspectives in biology.

[65]  C. Chuong,et al.  Competitive balance of intrabulge BMP/Wnt signaling reveals a robust gene network ruling stem cell homeostasis and cyclic activation , 2013, Proceedings of the National Academy of Sciences.

[66]  Jill P. Mesirov,et al.  β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis , 2012, Cell.

[67]  R. Moon,et al.  WNT signalling pathways as therapeutic targets in cancer , 2012, Nature Reviews Cancer.

[68]  Yonghe Li,et al.  Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. , 2012, Cellular signalling.

[69]  Shuji Ogino,et al.  Restriction of intestinal stem cell expansion and the regenerative response by YAP , 2012, Nature.

[70]  C. Niehrs.  The complex world of WNT receptor signalling , 2012, Nature Reviews Molecular Cell Biology.

[71]  B. R. Bowman,et al.  Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin , 2012, Proceedings of the National Academy of Sciences.

[72]  B. Merrill.  Wnt pathway regulation of embryonic stem cell self-renewal. , 2012, Cold Spring Harbor perspectives in biology.

[73]  D. Carrasco,et al.  Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling , 2012, Science Translational Medicine.

[74]  H. Clevers,et al.  Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors , 2012, Nature.

[75]  K. Garcia,et al.  Structural Basis of Wnt Recognition by Frizzled , 2012, Science.

[76]  F. Camargo,et al.  The Hippo signaling pathway and stem cell biology. , 2012, Trends in cell biology.

[77]  J. Helms,et al.  Wntless functions in mature osteoblasts to regulate bone mass , 2012, Proceedings of the National Academy of Sciences.

[78]  Andreas Hierholzer,et al.  Wnt/β-Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells , 2012, Science.

[79]  P. Polakis.  Drugging Wnt signalling in cancer , 2012, The EMBO journal.

[80]  H. Varmus,et al.  Three decades of Wnts: a personal perspective on how a scientific field developed , 2012, The EMBO journal.

[81]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[82]  Sridhar Ramaswamy,et al.  RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis , 2012, Nature.

[83]  Xizhi Guo,et al.  Wls-mediated Wnts differentially regulate distal limb patterning and tissue morphogenesis. , 2012, Developmental biology.

[84]  Jie Hyun Kim,et al.  Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. , 2012, International journal of oncology.

[85]  H. Ruffner,et al.  ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner , 2012, Nature.

[86]  B. Snel,et al.  The R-spondin protein family , 2012, Genome Biology.

[87]  H. Dinh,et al.  A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. , 2012, Cancer research.

[88]  A. M. Arias,et al.  Wnt‐Notch signalling: An integrated mechanism regulating transitions between cell states , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[89]  N. Gough.  Focus Issue: Wnt and β-Catenin Signaling in Development and Disease , 2012, Science Signaling.

[90]  N. Lin,et al.  Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction. , 2012, Biochemistry.

[91]  C. Nguyên,et al.  Wnt Signaling Orchestration with a Small Molecule DYRK Inhibitor Provides Long‐Term Xeno‐Free Human Pluripotent Cell Expansion , 2012, Stem cells translational medicine.

[92]  G. Reifenberger,et al.  The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis , 2012, EMBO molecular medicine.

[93]  M. Capecchi,et al.  The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations , 2011, Proceedings of the National Academy of Sciences.

[94]  G. Piazza,et al.  Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway , 2011, PloS one.

[95]  K. Aldape,et al.  Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation , 2011, Nature.

[96]  J. Strovel,et al.  AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model , 2011, Blood cancer journal.

[97]  W. Yung,et al.  FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. , 2011, Cancer cell.

[98]  O. Klein,et al.  A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable , 2011, Nature.

[99]  C. Schaniel,et al.  Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. , 2011, Blood.

[100]  Hans Clevers,et al.  Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling , 2011, Nature.

[101]  T. Kipps,et al.  Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells , 2011, Proceedings of the National Academy of Sciences.

[102]  T. Schroeder,et al.  Wnt to notch relay signaling induces definitive hematopoiesis. , 2011, Cell stem cell.

[103]  Q. Lin,et al.  R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling , 2011, Proceedings of the National Academy of Sciences.

[104]  Wei Chen,et al.  Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. , 2011, Cancer research.

[105]  T. He,et al.  BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. , 2011, Current gene therapy.

[106]  Randy L. Johnson,et al.  Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size , 2011, Science.

[107]  A. Säämänen,et al.  Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. , 2011, Experimental cell research.

[108]  Kenneth H. Buetow,et al.  CREBBP mutations in relapsed acute lymphoblastic leukaemia , 2011, Nature.

[109]  R. Dasgupta,et al.  An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway , 2011, Proceedings of the National Academy of Sciences.

[110]  Susan Grepper,et al.  Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin , 2011, Molecular Cancer.

[111]  T. He,et al.  Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer , 2011, Molecular Pharmacology.

[112]  M. Chevallier,et al.  Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma. , 2011, Journal of hepatology.

[113]  Wei Hsu,et al.  Gpr177/mouse Wntless is essential for Wnt‐mediated craniofacial and brain development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[114]  T. He,et al.  Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. , 2011, International journal of oncology.

[115]  P. Eliat,et al.  Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin , 2011, Oncogene.

[116]  Bruce J. Melancon,et al.  Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. , 2010, Nature chemical biology.

[117]  A. Fainsod,et al.  Oct‐3/4 regulates stem cell identity and cell fate decisions by modulating Wnt/β‐catenin signalling , 2010, The EMBO journal.

[118]  K. Basler,et al.  Wnt Trafficking: New Insights into Wnt Maturation, Secretion and Spreading , 2010, Traffic.

[119]  M. Bienz,et al.  Allosteric Remodelling of the Histone H3 Binding Pocket in the Pygo2 PHD Finger Triggered by Its Binding to the B9L/BCL9 Co-Factor , 2010, Journal of molecular biology.

[120]  Graeme I Murray,et al.  Current and emerging concepts in tumour metastasis , 2010, The Journal of pathology.

[121]  Yang Bi,et al.  Mesenchymal stem cells: Molecular characteristics and clinical applications. , 2010, World journal of stem cells.

[122]  S. Karlsson,et al.  Canonical BMP signaling is dispensable for hematopoietic stem cell function in both adult and fetal liver hematopoiesis, but essential to preserve colon architecture. , 2010, Blood.

[123]  M. Broggini,et al.  Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways. , 2010, European journal of cancer.

[124]  Samuel So,et al.  Small molecule antagonists of Tcf4/β‐catenin complex inhibit the growth of HCC cells in vitro and in vivo , 2010, International journal of cancer.

[125]  Mariann Bienz,et al.  Stability elements in the LRP6 cytoplasmic tail confer efficient signalling upon DIX-dependent polymerization , 2010, Journal of Cell Science.

[126]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[127]  D. Geerts,et al.  MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3. , 2010, Cancer letters.

[128]  X. Zi,et al.  Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma , 2010, Molecular Cancer Therapeutics.

[129]  W. Birchmeier,et al.  Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. , 2010, Cold Spring Harbor perspectives in biology.

[130]  C. Moreno.  The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. , 2010, The American journal of pathology.

[131]  Hans Clevers,et al.  Coexistence of Quiescent and Active Adult Stem Cells in Mammals , 2010, Science.

[132]  Robin S. Dothager,et al.  Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer , 2009, Clinical Cancer Research.

[133]  K. Aldape,et al.  EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. , 2009, Molecular cell.

[134]  K. Kawakami,et al.  Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. , 2009, Cancer research.

[135]  X. Ren,et al.  The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. , 2009, Biochemistry.

[136]  W. Hsu,et al.  Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation , 2009, Proceedings of the National Academy of Sciences.

[137]  Kathleen R. Cho,et al.  IRS1 Regulation by Wnt/β-Catenin Signaling and Varied Contribution of IRS1 to the Neoplastic Phenotype , 2009, The Journal of Biological Chemistry.

[138]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[139]  H. Pasolli,et al.  Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia , 2009, Nature Genetics.

[140]  Susan Grepper,et al.  Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells , 2009, Molecular Cancer.

[141]  J. Lucas,et al.  2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer. , 2009, Bioorganic & medicinal chemistry letters.

[142]  T. He,et al.  BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling , 2009, Journal of cellular and molecular medicine.

[143]  M. Aoki,et al.  Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. , 2009, Gastroenterology.

[144]  Byeong-Moo Kim,et al.  New insights into the role of Hedgehog signaling in gastrointestinal development and cancer. , 2009, Gastroenterology.

[145]  K. Basler,et al.  The PHD domain is required to link Drosophila Pygopus to Legless/β-catenin and not to histone H3 , 2009, Mechanisms of Development.

[146]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[147]  Marc Ladanyi,et al.  WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis , 2009, Cell.

[148]  Nobue Itasaki,et al.  Crosstalk between Wnt and bone morphogenic protein signaling: A turbulent relationship , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[149]  C. Lengner,et al.  Metastable pluripotent states in NOD-mouse-derived ESCs. , 2009, Cell stem cell.

[150]  I. Bisson,et al.  WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics , 2009, Cell Research.

[151]  P. Gunaratne,et al.  Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. , 2009, Human pathology.

[152]  J. Wands,et al.  Overexpression of insulin receptor substrate‐1 and hepatitis Bx genes causes premalignant alterations in the liver , 2009, Hepatology.

[153]  Kira T. Pate,et al.  Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression , 2009, BMC Cancer.

[154]  M. Fortini,et al.  Notch signaling: the core pathway and its posttranslational regulation. , 2009, Developmental cell.

[155]  Jie J. Zheng,et al.  Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled* , 2009, The Journal of Biological Chemistry.

[156]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[157]  S. Artavanis-Tsakonas,et al.  Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.

[158]  David M. Thomas,et al.  Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. , 2009, The Journal of clinical investigation.

[159]  P. Ip,et al.  Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through β-catenin , 2009, Modern Pathology.

[160]  Hans Clevers,et al.  Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fate , 2009, Cell.

[161]  M. Hallek,et al.  Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells , 2009, European journal of haematology.

[162]  Xiao Yong Yang,et al.  Modulation of the β-Catenin Signaling Pathway by the Dishevelled-Associated Protein Hipk1 , 2009, PloS one.

[163]  Frank J T Staal,et al.  Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. , 2009, Blood.

[164]  Lawrence Lum,et al.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer , 2008, Nature chemical biology.

[165]  S. Hayward,et al.  Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis , 2008, Oncogene.

[166]  J. Rottman,et al.  The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair , 2008, Proceedings of the National Academy of Sciences.

[167]  M. Cosma,et al.  Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. , 2008, Cell stem cell.

[168]  V. Grachtchouk,et al.  Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling , 2008, Nature Genetics.

[169]  N. Nara,et al.  Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3A. , 2008, Anticancer research.

[170]  A. Muñoz,et al.  Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. , 2008, Anticancer research.

[171]  T. Clemens,et al.  Smad7 Stabilizes β-Catenin Binding to E-cadherin Complex and Promotes Cell-Cell Adhesion* , 2008, Journal of Biological Chemistry.

[172]  Jie J. Zheng,et al.  Characterization of the Kremen-binding Site on Dkk1 and Elucidation of the Role of Kremen in Dkk-mediated Wnt Antagonism* , 2008, Journal of Biological Chemistry.

[173]  Richard A Young,et al.  Wnt signaling promotes reprogramming of somatic cells to pluripotency. , 2008, Cell stem cell.

[174]  Xi He,et al.  DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation* , 2008, Journal of Biological Chemistry.

[175]  K. Hotzel,et al.  Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. , 2008, Cancer research.

[176]  A. Abo,et al.  R-Spondin family members regulate the Wnt pathway by a common mechanism. , 2008, Molecular biology of the cell.

[177]  R. Baron,et al.  Christof Niehrs Kremen Induces Limb Defects and High Targeted Disruption of the Wnt Regulator Supplemental Material , 2008 .

[178]  F. Wendler,et al.  In vivo role of lipid adducts on Wingless , 2008, Journal of Cell Science.

[179]  T. Yao,et al.  HDAC6 Is Required for Epidermal Growth Factor-induced β-Catenin Nuclear Localization* , 2008, Journal of Biological Chemistry.

[180]  Kosuke Yanai,et al.  Crosstalk of hedgehog and Wnt pathways in gastric cancer. , 2008, Cancer letters.

[181]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[182]  Ji-yong Wang,et al.  Nuclear Dvl, c-Jun, β-catenin, and TCF form a complex leading to stabiLization of β-catenin–TCF interaction , 2008, The Journal of cell biology.

[183]  F. Dammacco,et al.  Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström's Macroglobulinemia , 2008, Clinical Cancer Research.

[184]  G. Keller,et al.  Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. , 2008, Cell stem cell.

[185]  T. Reya,et al.  Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo , 2007 .

[186]  Chika Yokota,et al.  Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions , 2007, Development.

[187]  J. Kench,et al.  Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma , 2007, PloS one.

[188]  P. Valent,et al.  CD44‐positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2) , 2007, The Journal of pathology.

[189]  Tetsuya Nakamura,et al.  Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision , 2007, Journal of Gastroenterology.

[190]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[191]  Philippe Blache,et al.  Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium , 2007, The Journal of cell biology.

[192]  Christof Niehrs,et al.  Wnt Induces LRP6 Signalosomes and Promotes Dishevelled-Dependent LRP6 Phosphorylation , 2007, Science.

[193]  H. Koeppen,et al.  The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. , 2007, Cancer research.

[194]  B. Doble,et al.  R-spondin1 Is a High Affinity Ligand for LRP6 and Induces LRP6 Phosphorylation and β-Catenin Signaling* , 2007, Journal of Biological Chemistry.

[195]  Keith Brennan,et al.  Cooperation between Wnt and Notch signalling in human breast cancer , 2007, Breast Cancer Research.

[196]  David S. Parker,et al.  CBP/p300 are bimodal regulators of Wnt signaling , 2007, The EMBO journal.

[197]  Cu Nguyen,et al.  Wnt/β-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency , 2007, Proceedings of the National Academy of Sciences.

[198]  Hideki Yamamoto,et al.  Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling. , 2007, The Biochemical journal.

[199]  Elaine Fuchs,et al.  Scratching the surface of skin development , 2007, Nature.

[200]  P. Comoglio,et al.  A positive feedback loop between hepatocyte growth factor receptor and β-catenin sustains colorectal cancer cell invasive growth , 2007, Oncogene.

[201]  P. Polakis.  The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.

[202]  K. Uematsu,et al.  An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. , 2007, Cancer research.

[203]  T. He,et al.  Wnt signaling and human diseases: what are the therapeutic implications? , 2007, Laboratory Investigation.

[204]  N. Ueno,et al.  Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. , 2006, Developmental cell.

[205]  Fiona M Watt,et al.  Jagged 1 is a β-catenin target gene required for ectopic hair follicle formation in adult epidermis , 2006 .

[206]  B. Cieply,et al.  Activation of Wnt/β‐catenin pathway during hepatocyte growth factor–induced hepatomegaly in mice , 2006, Hepatology.

[207]  P. Dijke,et al.  Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development , 2006 .

[208]  M. Katoh,et al.  Cross-talk of WNT and FGF signaling pathways at GSK3ß to regulate ß-catenin and SNAIL signaling cascades , 2006, Cancer biology & therapy.

[209]  Jun Yao,et al.  Growth suppression induced by Notch1 activation involves Wnt—β‐catenin down‐regulation in human tongue carcinoma cells , 2006, Biology of the cell.

[210]  Cornel Catana,et al.  Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening , 2006, Proteins.

[211]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[212]  Sangdun Choi,et al.  Mouse Cristin/R-spondin Family Proteins Are Novel Ligands for the Frizzled 8 and LRP6 Receptors and Activate β-Catenin-dependent Gene Expression* , 2006, Journal of Biological Chemistry.

[213]  K. Basler,et al.  Wntless, a Conserved Membrane Protein Dedicated to the Secretion of Wnt Proteins from Signaling Cells , 2006, Cell.

[214]  D. Wazer,et al.  Suppression of Wnt Signaling by the Green Tea Compound (–)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells , 2006, Journal of Biological Chemistry.

[215]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[216]  C. Brisken,et al.  Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[217]  A. Abo,et al.  R-Spondin Proteins: A Novel Link to β-catenin Activation , 2006 .

[218]  O. Franco,et al.  Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. , 2005, Cancer research.

[219]  Jie J. Zheng,et al.  Identification of a specific inhibitor of the dishevelled PDZ domain. , 2005, Biochemistry.

[220]  Yukinori Endo,et al.  Regulation of Slug transcription in embryonic ectoderm by β‐catenin‐Lef/Tcf and BMP‐Smad signaling , 2005, Development, growth & differentiation.

[221]  C. Nguyên,et al.  ICG-001, A Novel Small Molecule Regulator of TCF/β-Catenin Masakatsu Transcription , 2005 .

[222]  C. Nguyên,et al.  Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[223]  Hans Clevers,et al.  Expression pattern of Wnt signaling components in the adult intestine. , 2005, Gastroenterology.

[224]  Xi He,et al.  SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor* , 2005, Journal of Biological Chemistry.

[225]  Peng Liu,et al.  Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling* , 2005, Journal of Biological Chemistry.

[226]  Xizhi Guo,et al.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.

[227]  N. Perrimon,et al.  Notch modulates Wnt signalling by associating with Armadillo/β-catenin and regulating its transcriptional activity , 2005, Development.

[228]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[229]  M. Scott,et al.  Communicating with Hedgehogs , 2005, Nature Reviews Molecular Cell Biology.

[230]  Chul-hak Yang,et al.  Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. , 2005, Biochemical and biophysical research communications.

[231]  Tannishtha Reya,et al.  Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance , 2005, Nature Immunology.

[232]  Zijie Sun,et al.  Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor. , 2005, Molecular endocrinology.

[233]  C. Heldin,et al.  Interaction between Smad7 and β-Catenin: Importance for Transforming Growth Factor β-Induced Apoptosis , 2005, Molecular and Cellular Biology.

[234]  A. Montag,et al.  Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[235]  N. Rosenblum,et al.  Smad1, β-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription , 2004, Development.

[236]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[237]  Jonathan M. Yingling,et al.  Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.

[238]  A. Wickrema,et al.  Differential requirements for survivin in hematopoietic cell development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[239]  R. Grosschedl,et al.  LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis. , 2004, Genes & development.

[240]  Mark L. Johnson,et al.  LRP5 and Wnt Signaling: A Union Made for Bone , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[241]  S. Farmer,et al.  Regulating the Balance between Peroxisome Proliferator-activated Receptor γ and β-Catenin Signaling during Adipogenesis , 2004, Journal of Biological Chemistry.

[242]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[243]  C. Niehrs,et al.  R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. , 2004, Developmental cell.

[244]  Hong Ma,et al.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[245]  D. Kimelman,et al.  Combinatorial gene regulation by Bmp and Wnt in zebrafish posterior mesoderm formation , 2004, Development.

[246]  C. V. van Blitterswijk,et al.  Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. , 2004, Tissue engineering.

[247]  M. Buendia,et al.  Acetylation of β-Catenin by p300 Regulates β-Catenin-Tcf4 Interaction , 2004, Molecular and Cellular Biology.

[248]  William Gaffield,et al.  Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation , 2004, Nature Genetics.

[249]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[250]  J. Kench,et al.  Membranous Expression of Secreted Frizzled-Related Protein 4 Predicts for Good Prognosis in Localized Prostate Cancer and Inhibits PC3 Cellular Proliferation in Vitro , 2004, Clinical Cancer Research.

[251]  Christian Sirard,et al.  Smad4 and β-Catenin Co-activators Functionally Interact with Lymphoid-enhancing Factor to Regulate Graded Expression of Msx2* , 2003, Journal of Biological Chemistry.

[252]  J. Christensen,et al.  A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. , 2003, Cancer research.

[253]  Christian Pilarsky,et al.  WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer , 2003, The Journal of pathology.

[254]  Alison Rowe,et al.  Wise, a context-dependent activator and inhibitor of Wnt signalling , 2003, Development.

[255]  A. Lowy,et al.  Adenomatous polyposis coli/beta-catenin interaction and downstream targets: altered gene expression in gastrointestinal tumors. , 2003, Clinical colorectal cancer.

[256]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[257]  Carlos L. Arteaga,et al.  Targeting the TGFβ signaling network in human neoplasia , 2003 .

[258]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[259]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[260]  J. Szatkowski,et al.  Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. , 2003, Cancer letters.

[261]  Hans Clevers,et al.  Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.

[262]  A. Jaiswal,et al.  β-Catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells , 2002, Oncogene.

[263]  A. Montag,et al.  Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcoma , 2002, International journal of cancer.

[264]  Tony Pawson,et al.  β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.

[265]  E. Miska,et al.  Acetylation of β-Catenin by CREB-binding Protein (CBP)* , 2002, The Journal of Biological Chemistry.

[266]  Jonathan R Pollack,et al.  A transcriptional response to Wnt protein in human embryonic carcinoma cells , 2002, BMC Developmental Biology.

[267]  U. Rüther,et al.  Wnt and Bmp signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. , 2002, Development.

[268]  Christof Niehrs,et al.  Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling , 2002, Nature.

[269]  G. Frantz,et al.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. , 2002, The American journal of pathology.

[270]  Baljit Singh,et al.  Oncogenic β-Catenin Is Required for Bone Morphogenetic Protein 4 Expression in Human Cancer Cells , 2002 .

[271]  Sandipan Chatterjee,et al.  Wnt/wingless Signaling Requires Bcl9/legless-mediated Recruitment of Pygopus to the Nuclear Beta-catenin-tcf Complex , 2022 .

[272]  A. Bell,et al.  Hepatocyte Growth Factor Induces Wnt-independent Nuclear Translocation of β-Catenin after Met-β-Catenin Dissociation in Hepatocytes , 2002 .

[273]  Hans Clevers,et al.  Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.

[274]  Choun-Ki Joo,et al.  Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.

[275]  M. Wiesmann,et al.  Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[276]  P. Ingham,et al.  Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.

[277]  S. Fukuda,et al.  Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. , 2001, Blood.

[278]  M. Herlyn,et al.  Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and β-Catenin Pathways , 2001 .

[279]  M. van den Heuvel.  Fat Hedgehogs, Slower or Richer? , 2001, Science's STKE.

[280]  W. Birchmeier,et al.  β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin , 2001, Cell.

[281]  J. Taipale,et al.  The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.

[282]  A. McMahon,et al.  Activation of expression of hedgehog target genes in basal cell carcinomas. , 2001, The Journal of investigative dermatology.

[283]  L. Attisano,et al.  Transcriptional Regulation by Smads: Crosstalk between the TGF-&bgr; and Wnt Pathways , 2001, The Journal of bone and joint surgery. American volume.

[284]  A. Siermann,et al.  The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling , 2001, Oncogene.

[285]  F. Bertrand,et al.  Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation , 2001, Oncogene.

[286]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[287]  Andrew Tomlinson,et al.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling , 2000, Nature.

[288]  L. Attisano,et al.  Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[289]  Nakopoulou,et al.  c‐met tyrosine kinase receptor expression is associated with abnormal β‐catenin expression and favourable prognostic factors in invasive breast carcinoma , 2000, Histopathology.

[290]  M. Hull,et al.  The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. , 2000, European journal of cancer.

[291]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[292]  K. Hofmann.  A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. , 2000, Trends in biochemical sciences.

[293]  Naoto Ueno,et al.  Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer , 2000, Nature.

[294]  F. Luyten,et al.  Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick development. , 2000, Developmental biology.

[295]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[296]  E. Fuchs,et al.  Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. , 1999, Development.

[297]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[298]  S. Artavanis-Tsakonas,et al.  Notch signaling: cell fate control and signal integration in development. , 1999, Science.

[299]  J. Nathans,et al.  A new secreted protein that binds to Wnt proteins and inhibits their activites , 1999, Nature.

[300]  Hans Clevers,et al.  Drosophila Tcf and Groucho interact to repress Wingless signalling activity , 1998, Nature.

[301]  Hans Clevers,et al.  The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors , 1998, Nature.

[302]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[303]  Y. Nakamura,et al.  Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. , 1998, Cancer research.

[304]  R. Moon,et al.  BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm , 1998, Mechanisms of Development.

[305]  C. Niehrs,et al.  Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction , 1998, Nature.

[306]  H. Varmus,et al.  Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[307]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[308]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[309]  N. Perrimon,et al.  The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. , 1996, Genes & development.

[310]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[311]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[312]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[313]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[314]  Jeremy Nathans,et al.  A new member of the frizzled family from Drosophila functions as a Wingless receptor , 1996, Nature.

[315]  N. Perrimon,et al.  Interaction Between Wingless and Notch Signaling Pathways Mediated by Dishevelled , 1996, Science.

[316]  P. Leder,et al.  Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[317]  S. Hirohashi,et al.  c-erbB-2 gene product associates with catenins in human cancer cells. , 1994, Biochemical and biophysical research communications.

[318]  Norbert Perrimon,et al.  dishevelled and armadillo act in the Wingless signalling pathway in Drosophila , 1994, Nature.

[319]  Norbert Perrimon,et al.  Components of wingless signalling in Drosophila , 1994, Nature.

[320]  F. Masiarz,et al.  Association of the APC gene product with beta-catenin. , 1993, Science.

[321]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[322]  G. Peters,et al.  Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model. , 1993, Virology.

[323]  H. Varmus,et al.  Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[324]  N. Perrimon,et al.  wingless signaling acts through zeste-white 3, the drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate , 1992, Cell.

[325]  E. Wieschaus,et al.  The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties , 1992, The Journal of cell biology.

[326]  K. Kinzler,et al.  Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[327]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[328]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[329]  Detlef Weigel,et al.  The Drosophila homology of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless , 1987, Cell.

[330]  D. Cox,et al.  Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15 , 1984, Nature.

[331]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[332]  C. Nüsslein-Volhard,et al.  Mutations affecting segment number and polarity in Drosophila , 1980, Nature.

[333]  T. He,et al.  Canonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). , 2015, Biomaterials.

[334]  M. Kahn,et al.  Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem‐like phenotype through modulation of the PI3K/Akt/β‐catenin/CBP pathway , 2014, International journal of cancer.

[335]  T. He,et al.  The therapeutic potential of the Wnt signaling pathway in bone disorders. , 2011, Current molecular pharmacology.

[336]  Hideki Yamamoto,et al.  New insights into the mechanism of Wnt signaling pathway activation. , 2011, International review of cell and molecular biology.

[337]  G. Zaman,et al.  New avenues to target Wnt/β-catenin signaling. , 2011, Drug discovery today.

[338]  G. Zacchetti,et al.  Hedgehog pathway activity is required for the lethality and intestinal phenotypes of mice with hyperactive Wnt signaling , 2010, Mechanisms of Development.

[339]  S. Eksborg,et al.  Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. , 2010, Cancer research.

[340]  S. Magness,et al.  Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9. , 2008, Endocrinology.

[341]  T. Reya,et al.  Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. , 2007, Cancer cell.

[342]  A. Abo,et al.  R-Spondin proteins: a novel link to beta-catenin activation. , 2006, Cell cycle.

[343]  Xia Lin,et al.  Smad7-induced beta-catenin degradation alters epidermal appendage development. , 2006, Developmental cell.

[344]  C. Nguyên,et al.  ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

[345]  C. Heldin,et al.  Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. , 2005, Molecular and cellular biology.

[346]  Amie Y Lee,et al.  Efficacy of Wnt-1 monoclonal antibody in sarcoma cells , 2005, BMC Cancer.

[347]  J. Yingling,et al.  Development of TGF-beta signalling inhibitors for cancer therapy. , 2004, Nature reviews. Drug discovery.

[348]  S. Farmer,et al.  Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. , 2004, The Journal of biological chemistry.

[349]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. , 2004, Cancer cell.

[350]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[351]  Amie Y Lee,et al.  A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. , 2004, Neoplasia.

[352]  C. Nguyên,et al.  A small molecule inhibitor of -cateninCREB-binding protein transcription , 2004 .

[353]  Lin Chang-min,et al.  Beta-catenin controls hair follicle morphogenesis and stem cell differentiation , 2004 .

[354]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex , 2004 .

[355]  C. Arteaga,et al.  Targeting the TGF beta signaling network in human neoplasia. , 2003, Cancer cell.

[356]  A. Jaiswal,et al.  Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. , 2002, Oncogene.

[357]  Baljit Singh,et al.  Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. , 2002, Cancer research.

[358]  A. Bell,et al.  Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. , 2002, Cancer research.

[359]  Christof Niehrs,et al.  Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. , 2002, Nature.

[360]  E. Miska,et al.  Acetylation of beta-catenin by CREB-binding protein (CBP). , 2002, The Journal of biological chemistry.

[361]  F. Bertrand,et al.  Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. , 2001, Oncogene.

[362]  M. Herlyn,et al.  Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. , 2001, Cancer research.

[363]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[364]  K. Kinzler,et al.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. , 1999, Cell.

[365]  B. Vogelstein,et al.  Landscaping the cancer terrain. , 1998, Science.

[366]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.